TYRP1-TriNKET

N/A

Report date: 2025/05/14 15:50:05

Base Information

Drug NameTYRP1-TriNKET

Drug Alias NameTYRP1-TriNKET

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody

Mechanisms of ActionAnti-TYRP1NKG2-D type II integral membrane protein antagonistsAnti-Low affinity immunoglobulin gamma Fc region receptor III-A

TargetsTyrosinase-related protein 1NKG2-D type II integral membrane proteinLow affinity immunoglobulin gamma Fc region receptor III-A

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDragonfly Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesDragonfly Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A